Ferrão-Gonzales Astria D, Robbs Bruno K, Moreau Vitor Hugo, Ferreira Aricéle, Juliano Luiz, Valente Ana Paula, Almeida Fabio C L, Silva Jerson L, Foguel Debora
Instituto de Bioquímica Médica, Programa de Biologia Estrutural, Centro Nacional de Ressonāncia Magnética Nuclear, Universidade Federal do Rio de Janeiro, Av. Bauhínia, 400-21941-590-Rio de Janeiro, RJ, Brazil.
J Biol Chem. 2005 Oct 14;280(41):34747-54. doi: 10.1074/jbc.M501651200. Epub 2005 Jul 22.
Aggregation of proteins and peptides has been shown to be responsible for several diseases known as amyloidoses, which include Alzheimer disease (AD), prion diseases, among several others. AD is a neurodegenerative disorder caused primarily by the aggregation of beta-amyloid peptide (Abeta). Here we describe the stabilization of small oligomers of Abeta by the use of sulfonated hydrophobic molecules such as AMNS (1-amino-5-naphthalene sulfonate); 1,8-ANS (1-anilinonaphthalene-8-sulfonate) and bis-ANS (4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonate). The experiments were performed with either Abeta-1-42 or with Abeta-13-23, a shorter version of Abeta that is still able to form amyloid fibrils in vitro and contains amino acid residues 16-20, previously shown to be essential to peptide-peptide interaction and fibril formation. All sulfonated molecules tested were able to prevent Abeta aggregation in a concentration dependent fashion in the following order of efficacy: 1,8-ANS < AMNS < bis-ANS. Size exclusion chromatography revealed that in the presence of bis-ANS, Abeta forms a heterogeneous population of low molecular weight species that proved to be toxic to cell cultures. Since the ANS compounds all have apolar rings and negative charges (sulfonate groups), both hydrophobic and electrostatic interactions may contribute to interpeptide contacts that lead to aggregation. We also performed NMR experiments to investigate the structure of Abeta-13-23 in SDS micelles and found features of an alpha-helix from Lys(16) to Phe(20). 1H TOCSY spectra of Abeta-13-23 in the presence of AMNS displayed a chemical-shift dispersion quite similar to that observed in SDS, which suggests that in the presence of AMNS this peptide might adopt a conformation similar to that reported in the presence of SDS. Taken together, our studies provide evidence for the crucial role of small oligomers and their stabilization by sulfonate hydrophobic compounds.
蛋白质和肽的聚集已被证明是导致几种被称为淀粉样变性疾病的原因,其中包括阿尔茨海默病(AD)、朊病毒疾病等。AD是一种主要由β-淀粉样肽(Aβ)聚集引起的神经退行性疾病。在这里,我们描述了通过使用磺化疏水分子如AMNS(1-氨基-5-萘磺酸盐)、1,8-ANS(1-苯胺基萘-8-磺酸盐)和双ANS(4,4'-二苯胺基-1,1'-联萘-5,5'-二磺酸盐)来稳定Aβ的小寡聚体。实验使用Aβ-1-42或Aβ-13-23进行,Aβ-13-23是Aβ的较短版本,仍能够在体外形成淀粉样原纤维,并且包含先前已证明对肽-肽相互作用和原纤维形成至关重要的16-20位氨基酸残基。所有测试的磺化分子都能够以浓度依赖的方式防止Aβ聚集,其功效顺序如下:1,8-ANS < AMNS < 双ANS。尺寸排阻色谱显示,在双ANS存在下,Aβ形成了异质的低分子量物种群体,事实证明这些物种对细胞培养有毒。由于ANS化合物都具有非极性环和负电荷(磺酸盐基团),疏水和静电相互作用都可能有助于导致聚集的肽间接触。我们还进行了核磁共振实验,以研究Aβ-13-23在SDS胶束中的结构,并发现了从Lys(16)到Phe(20)的α-螺旋特征。在AMNS存在下Aβ-13-23的1H TOCSY谱显示出与在SDS中观察到的相当相似的化学位移分散,这表明在AMNS存在下该肽可能采用与在SDS存在下报道的相似的构象。综上所述,我们的研究为小寡聚体及其通过磺酸盐疏水化合物的稳定化的关键作用提供了证据。